Strategic COVID-19 Testing Could Prevent Distancing, Shutdowns
Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read MorePosted by Chris Wolski | Nov 1, 2021 | Covid 19, POC Rapid Assays |
Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read MorePosted by Chris Wolski | Nov 1, 2021 | Hematology Instrumentation |
A wearable device that “reads” blood through the skin could reduce racial disparities in blood measurements.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Cancer, Cardiovascular, Computing Systems, Covid 19 |
Researchers are developing a deep learning network capable of detecting disease biomarkers with a much higher degree of accuracy.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BARDA will invest $24.7 million for BD to develop five new COVID-19 combination diagnostic tests for core labs, hospitals, and point-of-care locations.
Read MorePosted by Chris Wolski | Oct 29, 2021 | Covid 19, Flu & Respiratory Infections, Immunoassay Reagents & test Kits |
The Aptima SARS-CoV-2/Flu Assay from Hologic tests simultaneously for SARS-CoV-2, influenza A, and influenza B on the Panther molecular diagnostics system.
Read More